Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1831-1840 of 2869 for cancer

Edit search filters
  1. A Study For Women Who Have Platinum Resistant Ovarian Cancer To Evaluate EC145 Combined With Pegylated Liposomal Doxorubicin, Compared To Pegylated Liposomal Doxorubicin Alone

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Testing The Addition Of High Dose, Targeted Radiation To The Usual Treatment For Locally-Advanced Inoperable Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Cetuximab With Or Without Tivantinib In Treating Patients With Head And Neck Cancer That Is Recurrent, Metastatic, Or Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Study Of Pembrolizumab (MK-3475) Compared To Platinum-Based Chemotherapies In Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)

    Rochester, MN

  5. A Study Of ASP8273 Versus Erlotinib Or Gefitinib As First-Line Treatment For Patients With Stage IIIB/IV Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Alisertib And Fulvestrant In Treating Patients With Hormone Receptor Positive Breast Cancer That Is Metastatic Or Locally Advanced And Cannot Be Removed By Surgery

    Rochester, MN

  7. Transoral Surgery Followed By Low-Dose Or Standard-Dose Radiation Therapy With Or Without Chemotherapy In Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

    Scottsdale/Phoenix, AZ

  8. Phase II Trial Of Standard Chemotherapy +Various Proton Beam Therapy (PBT) Doses For Unresectable Stage 2/3 Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Pharmacokinetic And Safety Study Of Nab ®-Paclitaxel (ABI-007) Plus Gemcitabine In Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubenemia

    Scottsdale/Phoenix, AZ

  10. Irinotecan And Cetuximab With Or Without Bevacizumab In Treating Patients With RAS Wild-Type Locally Advanced Or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer